Relationship between gentamicin administration and ductal patency in very low birth weight infants
CONCLUSION: In our study, it was found that ductal contraction decreased and hsPDA rate increased as the rate and duration of gentamicin increased.PMID:34082688 | DOI:10.2174/1574884716666210603110412 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - June 4, 2021 Category: Drugs & Pharmacology Authors: Ufuk Cakir Cuneyt Tayman Source Type: research
Relationship between gentamicin administration and ductal patency in very low birth weight infants
CONCLUSION: In our study, it was found that ductal contraction decreased and hsPDA rate increased as the rate and duration of gentamicin increased.PMID:34082688 | DOI:10.2174/1574884716666210603110412 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - June 4, 2021 Category: Drugs & Pharmacology Authors: Ufuk Cakir Cuneyt Tayman Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development
CONCLUSION: We recommend using the Patient Motivation Pyramid as structural approach for identifying elements of patient-centricity. Secondly we recommend to start using patient-centric approaches in an early phase of the medicine's lifecycle.PMID:33906590 | DOI:10.2174/1574884716666210427115820 (Source: Current Clinical Pharmacology)
Source: Current Clinical Pharmacology - April 28, 2021 Category: Drugs & Pharmacology Authors: Thijs van Iersel Jocelyn Courville Cathalijne van Doorne Remco A Koster Christina Fawcett Source Type: research
